Literature DB >> 21107325

Chronic hypertension with related drug treatment of pregnant women and congenital abnormalities in their offspring: a population-based study.

Ferenc Bánhidy1, Nándor Acs, Erzsébet H Puhó, Andrew E Czeizel.   

Abstract

Chronic hypertension (CH) is a common chronic disease and occurs frequently in pregnant women. The teratogenic/fetotoxic effect of certain antihypertensive drugs has been shown. The objective of this study was to investigate the association between pregnant women with CH and the possible risk of congenital abnormalities (CAs) among their offspring. The prevalence of medically recorded CH in the prenatal maternity logbook was compared between 1030 pregnant women who later had offspring with CA (case group) and 1579 pregnant women with CH who later delivered newborn infants without CA (control group). Control newborn infants were matched to cases in the population-based data set of the Hungarian Case-Control Surveillance System of Congenital Abnormalities during 1980-1996. Of 23 different CA groups with informative offspring, esophageal atresia/stenosis was a greater risk in pregnant women with CH (adjusted odds ratios with 95% confidence intervals: 3.1, 1.4-6.8). In conclusion, a higher risk of esophageal atresia/stenosis was found in the offspring of pregnant women with severe CH, which could not be explained by related drug treatments. This finding requires confirmation or lack thereof by future studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107325     DOI: 10.1038/hr.2010.227

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  11 in total

1.  Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study.

Authors:  Alissa R Van Zutphen; Martha M Werler; Marilyn M Browne; Paul A Romitti; Erin M Bell; Louise-Anne McNutt; Charlotte M Druschel; Allen A Mitchell
Journal:  Obstet Gynecol       Date:  2014-02       Impact factor: 7.661

2.  Maternal hypertension with nifedipine treatment associated with a higher risk for right-sided obstructive defects of the heart: a population-based case-control study.

Authors:  Melinda Csáky-Szunyogh; Attila Vereczkey; Balázs Gerencsér; Andrew E Czeizel
Journal:  Heart Asia       Date:  2014-01-23

Review 3.  Nongenetic risk factors and congenital heart defects.

Authors:  Sonali S Patel; Trudy L Burns
Journal:  Pediatr Cardiol       Date:  2013-08-21       Impact factor: 1.655

Review 4.  Intergenerational Effects of Health Issues Among Women of Childbearing Age: a Review of the Recent Literature.

Authors:  Lydi-Anne Vézina-Im; Theresa A Nicklas; Tom Baranowski
Journal:  Curr Nutr Rep       Date:  2018-12

5.  The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis.

Authors:  Mohammad Y Yakoob; Brian T Bateman; Eugenia Ho; Sonia Hernandez-Diaz; Jessica M Franklin; Julie E Goodman; Rebecca A Hoban
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

Review 6.  Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis.

Authors:  Anushuya Ramakrishnan; Laura J Lee; Laura E Mitchell; A J Agopian
Journal:  Pediatr Cardiol       Date:  2015-05-08       Impact factor: 1.655

7.  Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study.

Authors:  De-Kun Li; Chunmei Yang; Susan Andrade; Venessa Tavares; Jeannette R Ferber
Journal:  BMJ       Date:  2011-10-18

8.  Are hypertensive disorders in pregnancy associated with congenital malformations in offspring? Evidence from the WHO Multicountry cross sectional survey on maternal and newborn health.

Authors:  S Bellizzi; M M Ali; E Abalos; A P Betran; J Kapila; C Pileggi-Castro; J P Vogel; M Merialdi
Journal:  BMC Pregnancy Childbirth       Date:  2016-07-29       Impact factor: 3.007

9.  Safety of Amlodipine in Early Pregnancy.

Authors:  Asako Mito; Atsuko Murashima; Yoshinao Wada; Mai Miyasato-Isoda; Chizuko A Kamiya; Masako Waguri; Jun Yoshimatsu; Naho Yakuwa; Omi Watanabe; Tomo Suzuki; Naoko Arata; Masashi Mikami; Shinya Ito
Journal:  J Am Heart Assoc       Date:  2019-07-26       Impact factor: 5.501

10.  EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations.

Authors:  Joanne E Given; Maria Loane; Johannes M Luteijn; Joan K Morris; Lolkje T W de Jong van den Berg; Ester Garne; Marie-Claude Addor; Ingeborg Barisic; Hermien de Walle; Miriam Gatt; Kari Klungsoyr; Babak Khoshnood; Anna Latos-Bielenska; Vera Nelen; Amanda J Neville; Mary O'Mahony; Anna Pierini; David Tucker; Awi Wiesel; Helen Dolk
Journal:  Br J Clin Pharmacol       Date:  2016-07-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.